NIFTY 50▼25,014.60
-235.50 (-0.93%)
SENSEX▼81,688.45
-808.65 (-0.98%)
NIFTY BANK▼51,462.05
-383.15 (-0.74%)
TATA MOTORS▲930.75
5.05 (0.55%)
SUZLON ENERGY▼74.67
-1.08 (-1.43%)
TATA STEEL▼166.75
-0.23 (-0.14%)
INDIAN RAILWAY FINANCE CORP▲152.07
0.47 (0.31%)
TATA POWER▼466.65
-5.15 (-1.09%)
RAIL VIKAS NIGAM▼493.40
-16.10 (-3.16%)
VODAFONE IDEA▼9.79
-0.08 (-0.81%)
RELIANCE INDUSTRIES▼2,773.05
-40.90 (-1.45%)
INDIAN RENEWABLE ENERGY▼221.66
-1.66 (-0.74%)
ZOMATO▲275.30
6.30 (2.34%)
RELIANCE POWER▼50.95
-2.69 (-5.01%)
ADANI POWER▼642.10
-2.65 (-0.41%)
YES BANK▲21.95
0.09 (0.41%)
STATE BANK OF INDIA▲796.65
2.55 (0.32%)
NHPC▲93.17
0.21 (0.23%)
HDFC BANK▼1,657.65
-24.35 (-1.45%)
JIO FIN SERVICES LTD▼338.80
-6.80 (-1.97%)
OLA ELECTRIC MOBILITY LTD▼99.05
-0.21 (-0.21%)
BHARAT ELECTRONICS▼277.20
-1.50 (-0.54%)
ADANI PORT & SEZ▼1,413.70
-11.50 (-0.81%)
INDIAN OIL CORP▼168.65
-2.68 (-1.56%)
GTL INFRA▼2.31
-0.04 (-1.70%)
MRF▼1,33,408.75
-2695.60 (-1.98%)
JAIPRAKASH POWER VENTURES▼19.43
-0.67 (-3.33%)
INDIAN RAILWAY TOURISM CORP▼872.75
-13.65 (-1.54%)
34% Hold
Alkem Laboratories Share Price
ALKEM
₹6,194.15+₹34.85 (0.57%) TodayLast updated on 04 Oct, 2024 | 15:51 IST
Please wait...
What’s in news?
Company overview
Financial performance
Market cap
| Open₹6,175.00 | Close₹6,159.30 |
Circuit range₹6,775.20 - ₹5,543.40 | Day range₹6,083.35 - ₹6,320.00 | Year range₹3,447.00 - ₹6,439.90 |
Volume3,33,711 | Avg. traded₹6,255.69 | Revenue (12m)₹12,732 Crs |
Alkem LaboratoriesAlkem Laboratories Ltd. is an India-based pharmaceutical company with global operations, engaged in the development, manufacturing and sale of pharmaceutical and nutraceutical products. The Company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals, which it markets in India and international markets. It has a portfolio of more than 800 brands in India. The Company also has a presence in more than 40 international markets, with the United States being its key focus market. Its offerings include therapies, Rx products and Alkem generic. Its therapy offerings include anti-infective, anti-osteoporosis, cardiology, neurology, dermatology, diabetology, gastroenterology, gynecology, oncology, ophthalmology, respiratory, rheumatology and urology. Its product portfolio also includes mega-brands such as Clavam, Pan, Pan-D, and Taxim-O. Under the Alkem Generics cluster there are four divisions: Futura, Maxxio, Novokem and Alkem Healthcare.
Alkem Laboratories Key indicators
52 week high₹6,439.90 | 52 week low₹3,447.00 | P/E ratio35.85 |
P/B ratio6.82 | ROE17.56% | ROCE17.85% |
Dividend yield0.65% | Debt/Equity ratio0.09 | EPS146.14 |
Learn more
Featured in
Investment checklist: (5/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Hold
Analyst ratings:
Hold33%
Hold
34%
Sell
33%
This analysis is based on the reviews of 18 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin22.11% | Net profit margin17.01% |
ROE17.56% | ROA14.32% |
ROCE17.85% |
Learn more
Alkem Laboratories Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Oct 3 2024 | ₹6,140.00 | ₹6,159.30 | |
Tue, Oct 1 2024 | ₹6,099.00 | ₹6,151.25 | |
Mon, Sep 30 2024 | ₹6,184.60 | ₹6,052.80 | -2.13% |
Fri, Sep 27 2024 | ₹6,197.15 | ₹6,184.60 | -0.20% |
Thu, Sep 26 2024 | ₹6,209.05 | ₹6,197.15 | -0.47% |
Wed, Sep 25 2024 | ₹6,075.00 | ₹6,226.65 | |
Tue, Sep 24 2024 | ₹6,039.00 | ₹6,046.80 | |
Mon, Sep 23 2024 | ₹6,111.00 | ₹5,982.45 | -1.71% |
Events
Corporate actions
Dividend • ₹35/share
Ex date 16 Feb 2024
Dividend • ₹10/share
Ex date 10 Aug 2023
Dividend • ₹25/share
Ex date 17 Feb 2023
Dividend • ₹15/share
Ex date 17 Feb 2023
Dividend • ₹4/share
Ex date 08 Aug 2022
Dividend • ₹30/share
Ex date 10 Feb 2022
Dividend • ₹5/share
Ex date
Learn more